Pandion Therapeutics Inc (PAND) Stock Price & Overview

NASDAQ:PAND

60.05

+0.13 (+0.22%)

At close: Mar 31, 2021

60.05

0 (0%)

After Hours: 3/31/2021, 8:12:53 PM

The current stock price of PAND is 60.05 null. Today PAND is up by 0.22%. In the past month the price decreased by -2.56%.

PAND Key Statistics

52-Week Range10.28 - 62.9

1-Month Range59.6 - 61.92

Market Cap: 1.772B
P/E: N/A
Fwd P/E: N/A
EPS (TTM): -2.81
Dividend Yield: N/A

PAND Stock Performance

Today

+0.22%

1 Week

+0.13%

1 Month

-2.56%

3 Months

+304.38%

Longer-term

6 Months +440.02%

1 Year N/A

2 Years N/A

3 Years N/A

5 Years N/A

10 Years N/A

PAND Stock Chart

Pandion Therapeutics Inc / PAND Daily stock chart

PAND Technical Analysis

ChartMill assigns a technical rating of 6 / 10 to PAND.

Chartmill TA Rating

Chartmill Setup Rating

PAND Full Technical Analysis Report

PAND Fundamental Analysis

ChartMill assigns a fundamental rating of 1 / 10 to PAND. Both the profitability and financial health of PAND have multiple concerns.

Chartmill FA Analysis

Valuation

Growth

Profitability

Health

Dividend

PAND Full Fundamental Analysis Report

PAND Earnings

Next Earnings DateMar 11, 2022

Last Earnings DateN/A

PAND Earnings History

PAND Forecast & Estimates

Analysts

Analysts73.4

Price TargetN/A

EPS Next YN/A

Revenue Next YearN/A

PAND Forecast & Estimates

PAND Financial Highlights

Over the last trailing twelve months PAND reported a non-GAAP Earnings per Share(EPS) of -2.8116. The EPS increased by 86.71% compared to the year before.

Income Statements

Revenue(TTM)8.78M

Net Income(TTM)-38.10M

		Industry Rank	Sector Rank
PM (TTM)	-434.05%
ROA	N/A
ROE	N/A
Debt/Equity	N/A

Chartmill High Growth Momentum

EPS Q2Q%N/A

Sales Q2Q%N/A

EPS 1Y (TTM)86.71%

Revenue 1Y (TTM)807.86%

PAND financials

PAND Ownership

Ownership

Inst OwnersN/A

Shares29.52M

FloatN/A

Ins Owners19.35%

Short Float %N/A

Short RatioN/A

PAND Ownership

About PAND

Company Profile

Pandion Therapeutics Inc. is a biotechnology company. It focuses on developing modular proteins, antibodies and bispecifics for the treatment of autoimmune and inflammatory diseases. Pandion Therapeutics Inc. is based in North Cambridge, United States.

Company Info

Pandion Therapeutics Inc

134 COOLIDGE AVENUE 2ND FLOOR

WATERTOWN MA 02472

CEO: Rahul Kakkar

Phone: 617-393-5925

Pandion Therapeutics Inc / PAND FAQ

What does PAND do?

Can you provide the latest stock price for Pandion Therapeutics Inc?

The current stock price of PAND is 60.05 null. The price increased by 0.22% in the last trading session.

Does PAND stock pay dividends?

PAND does not pay a dividend.

What is the ChartMill technical and fundamental rating of PAND stock?

PAND has a ChartMill Technical rating of 6 out of 10 and a ChartMill Fundamental rating of 1 out of 10.

What is Pandion Therapeutics Inc worth?

Pandion Therapeutics Inc (PAND) has a market capitalization of 1.77B null. This makes PAND a Small Cap stock.